Viewing Study NCT00489359


Ignite Creation Date: 2025-12-24 @ 2:44 PM
Ignite Modification Date: 2026-02-20 @ 6:41 PM
Study NCT ID: NCT00489359
Status: COMPLETED
Last Update Posted: 2011-06-16
First Post: 2007-06-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer
Sponsor: Eli Lilly and Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Primary Peritoneal Cancer View
Keywords: